REGISTER
How dynamic MRD assessment can guide key treatment decisions in AML
Prof. Dai and Prof. Cluzeau discussed how dynamic MRD assessment can guide key treatment decisions in AML.

Prof. Haiping Dai, The First Affiliated Hospital of Soochow University, China
Prof. Thomas Cluzeau, Nice University Hospital, France


Prof. Dai and Prof. Cluzeau discussed how dynamic MRD assessment can guide key treatment decisions in AML, including transplant necessity, post-transplant intervention, and treatment intensification or de-escalation in non-transplant patients. They also shared perspectives based on the latest evidence and ASH updates on the growing role of MRD in individualized leukemia management.

0
0
Loading